Cameron (CAM)  - soon to be bought by Boston Scientific (BSX) - is -2.6% after FDA reviewers say...

|About: Cameron International Cor... (CAM)|By:, SA News Editor

Cameron (CAM)  - soon to be bought by Boston Scientific (BSX) - is -2.6% after FDA reviewers say they won't OK the firm's defibrillator until it resolves problems of the battery depleting too quickly. The reviewers also say the product, which is inserted under the skin, may have more infection issues and work slower than similar devices placed in the heart.